- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 30.07. | Promatix Biosciences Wins Innovate UK Grant for Cancer ADC Program | ||
| 30.07. | Ember, Alfresa to Partner on Cold Chain Quality Improvement in Japan | ||
| 30.07. | Shimadzu Launches GCMS-TQ RX Series | ||
| 30.07. | Lilly, Resilience to Invest $750M in Ohio Manufacturing | ||
| 30.07. | Johnson & Johnson Acquires Firefly Bio for $1B | ||
| 29.07. | FDA Approves Viatris Once-Weekly Contraceptive Patch | ||
| 29.07. | Octapharma to Build $1.5B Manufacturing Site in South Carolina | ||
| 29.07. | Landmark Bio, Syngoi Now to Operate Under Artis BioSolutions Name | ||
| 29.07. | Merck KGaA to Adopt Evinova AI-Native Platform to Accelerate Clinical R&D | ||
| 29.07. | AbCellera, Vertex Partner on T-Cell Engagers | ||
| 29.07. | 10x Genomics, Lausanne University Hospital Partner for Cancer Biomarker Research | ||
| 29.07. | Caldera Therapeutics to Go Public Through Synlogic Merger | ||
| 28.07. | Uniquity Bio Taps Jason Moore as New SVP of Regulatory & Quality | ||
| 28.07. | Celonic, Leukocare Partner to Support Joint Clients in Complex Biologics Development | ||
| 28.07. | Steriline Launches AI Tools for Sterile Fill-Finish Lines | ||
| 28.07. | ICON to Deploy Claude AI Across Clinical Trial Lifecycle | ||
| 28.07. | ProBioGen Partners with VarmX to Advance Factor X Candidate | ||
| 28.07. | Spruce Biosciences Welcomes Adrian Quartel as Chief Medical Officer | ||
| 28.07. | AsymBio Breaks Ground on New Fengxian R&D Building | ||
| 28.07. | Harbour BioMed and Sinopharm Will Establish R&D 'Innovation Consortium' | ||
| 24.07. | Asymchem Carbapenem API Site in China Successfully Completes First FDA Inspection | ||
| 24.07. | Federal Equipment Announces Turnkey Sale of Denison Pharmaceuticals Facility | ||
| 24.07. | Neurocrine Biosciences Names New Senior Vice Presidents | ||
| 24.07. | Vir Biotechnology Appoints Brent Sabatini as Interim Principal Financial Officer | ||
| 23.07. | FDA Approves NSCLC Treatment Acquired by GSK in Nuvalent Deal |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.